Bg pattern

ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Arixtra 2.5 mg/0.5 ml Solution for Injection

fondaparinux sodium

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

  1. What Arixtra is and what it is used for
  2. What you need to know before you use Arixtra
  3. How to use Arixtra
  4. Possible side effects
  5. Storage of Arixtra
  6. Contents of the pack and further information

1. What Arixtra is and what it is used for

Arixtra is a medicine that helps prevent blood clots from forming in the blood vessels (an antithrombotic agent).

Arixtra contains a synthetic substance called fondaparinux sodium. This stops the effect of factor Xa "ten-A" in the blood and thus prevents the formation of unwanted blood clots (thrombi) in the blood vessels.

Arixtra is used to:

  • prevent blood clots from forming in the blood vessels of the legs or lungs after orthopedic surgery, such as hip or knee surgery, or abdominal surgery
  • prevent blood clots from forming during and shortly after a period of restricted mobility due to an acute illness.
  • treat certain types of heart attack and severe angina (pain caused by narrowing of the heart arteries).
  • treat blood clots in the blood vessels that are near the surface of the skin of the legs (superficial vein thrombosis)
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Arixtra

Do not use Arixtra:

  • if you are allergicto fondaparinux sodium or any of the other ingredients of this medicine (listed in section 6).
  • if you are bleeding heavily
  • if you have a bacterial infection of the heart
  • if you have severe kidney disease.
  • Tell your doctorif you think you may be affected by any of these conditions. If so, you must notuse Arixtra.

Arixtra.

Warnings and precautions

Talk to your doctor or pharmacist before you start using Arixtra:

  • if you have had complications in the past during treatment with heparin or heparin-like medicines that cause a decrease in platelet count (heparin-induced thrombocytopenia)
  • if you have a risk of uncontrolled bleeding(hemorrhage), such as:
  • stomach ulcer
  • bleeding disorders
  • recent brain bleeding(intracranial hemorrhage)
  • recent brain, spinal, or eye surgery
  • if you have severe liver disease
  • if you have kidney disease
  • if you are 75 years or older
  • if you weigh less than 50 kg
  • Tell your doctorif you are affected by any of these conditions.

Children and adolescents

Arixtra has not been tested in children and adolescents under 17 years.

Using Arixtra with other medicines

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those obtained without a prescription. The use of other medicines may affect how Arixtra works or be affected by Arixtra.

Pregnancy and breastfeeding

Arixtra should not be prescribed to pregnant women unless strictly necessary. Breastfeeding is not recommended during treatment with Arixtra. If you are pregnant, breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.

Arixtra contains sodium

This medicine contains less than 23 mg of sodium per dose; it is essentially "sodium-free".

The Arixtra syringe may contain latex

The needle protector of the syringe may contain latex, which may cause allergic reactions in people sensitive to latex.

  • Tell your doctorif you are allergic to latex before being treated with Arixtra.

3. How to use Arixtra

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

The recommended dose is 2.5 mg once a day, injected at approximately the same time every day.

If you have kidney disease, the dose may be reduced to 1.5 mg once a day.How to administer Arixtra

  • Arixtra is administered by injection under the skin (subcutaneously) in a skin fold formed in the lower abdomen area. The syringes are pre-filled with the exact dose you need. There are different syringes for the 2.5 mg and 1.5 mg doses.For a detailed description of how to use Arixtra, see the end of the leaflet. To treatsome types of heart attacks, a healthcare professional may administer the first dose in a vein (intravenously).
  • Do notinject Arixtra into a muscle.

How long you should use Arixtra

You should use Arixtra for the period of time your doctor has told you, as Arixtra prevents you from having a serious illness.

If you inject more Arixtra than you should

Contact your doctor or pharmacist immediately because there is a higher risk of bleeding.If you forget to use Arixtra

  • Administer the dose as soon as you remember. Do not inject a double dose to make up for forgotten doses.
  • In case of doubt, contact your doctor or pharmacist.

If you stop using Arixtra

If you stop treatment before your doctor has told you to, you are at risk of developing a blood clot in a vein in your leg or lung. Before stopping treatment,contact your doctor or pharmacist.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Symptoms to look out for

Severe allergic reactions (anaphylaxis):are very rare (up to 1 in 10,000) in patients using Arixtra. The symptoms include:

  • swelling, sometimes of the face or mouth (angioedema), which causes difficulty swallowing or breathing
  • collapse.
  • Contact a doctor immediatelyif you experience these symptoms. Stop using Arixtra.

Common side effects

These may affect more than 1 in 100 patientstreated with Arixtra.

  • bleeding(e.g., from the area where the operation was performed, from a stomach ulcer, nosebleeds, bleeding gums, blood in the urine, coughing up blood, eye bleeding, bleeding into the joints, internal bleeding in the uterus)
  • localized accumulation of blood(in any organ or body tissue)
  • anemia(a reduction in the number of red blood cells)
  • bruising

Uncommon side effects

These may affect up to 1 in 100 patientstreated with Arixtra.

  • swelling (edema)
  • feeling or being sick (nausea or vomiting)
  • headache
  • pain
  • chest pain
  • difficulty breathing
  • skin rash or itching
  • wound secretion
  • fever
  • reduction or increase in the number of platelets (blood cells needed for clotting)
  • increase in some chemicals (enzymes) produced by the liver.

Rare side effects

These may affect up to 1 in 1,000 patientstreated with Arixtra.

  • allergic reaction (including itching, swelling, rash)
  • internal bleeding in the brain, liver, or abdomen
  • anxiety or confusion
  • fainting or dizziness, low blood pressure
  • drowsiness or fatigue
  • flushing
  • cough
  • leg pain or stomach pain
  • diarrhea or constipation
  • indigestion
  • pain and inflammation at the injection site
  • wound infection
  • increase in bilirubin (a substance produced by the liver) in the blood
  • increase in the amount of non-protein nitrogen in the blood
  • reduction of potassium in the blood
  • pain around the upper stomach or heartburn

If you experience side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Arixtra

  • Keep this medicine out of the sight and reach of children
  • Store below 25°C. Do not freeze
  • It is not necessary to store Arixtra in the refrigerator.

Do not use this medicine:

  • after the expiry date stated on the label and carton
  • if you notice particles in the solution or if the solution is discolored
  • if you notice that the syringe is damaged
  • if you have opened the syringe and are not going to use it immediately.

Disposal of syringes:

Medicines or syringes should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines or syringes no longer required. This will help protect the environment.

6. Container Content and Additional Information

Arixtra Composition

  • The active ingredient is 2.5 mg of fondaparinux sodium in 0.3 ml of injectable solution
  • The other components are sodium chloride, water for injectable preparations, and hydrochloric acid and/or sodium hydroxide to adjust the pH (see section 2).

Arixtra does not contain any animal products.

Product Appearance and Container Content

Arixtra is a clear and colorless injectable solution. It is presented in a pre-filled syringe for single use, equipped with a safety system that helps prevent accidental needlesticks after use. It is available in packs of 2, 7, 10, and 20 pre-filled syringes. Only some pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

Viatris Healthcare Limited, Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

Manufacturer:

Aspen Notre Dame de Bondeville, 1 rue de l'Abbaye, F-76960 Notre Dame de Bondeville, France.

Date of Last Revision of this Leaflet:

Other Sources of Information

Detailed information on this medicinal product is available on the European Medicines Agency website http://www.ema.europa.eu

You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder.

Belgium/Belgique/Belgien

Viatris

Tel: + 32 (0)2 658 61 00

Bulgaria

?????? ????

?: +359 2 44 55 400

Czech Republic

Viatris CZ s.r.o.

Tel: + 420 222 004 400

Lithuania

Viatris UAB

Tel: +370 5 205 1288

Luxembourg/Luxemburg

Viatris

Tel: + 32 (0)2 658 61 00

(Belgium/Belgien)

Hungary

Viatris Healthcare Kft.

Tel: + 36 1 465 2100

Denmark

Viatris ApS

Tel: +45 28 11 69 32

Malta

V.J. Salomone Pharma Ltd

Tel: + 356 21 22 01 74

Germany

Viatris Healthcare GmbH

Tel: +49 800 0700 800

Netherlands

Mylan Healthcare BV

Tel: +31 (0)20 426 3300

Estonia

Viatris OÜ

Tel: + 372 6363 052

Norway

Viatris AS

Tel: + 47 66 75 33 00

Greece

Viatris Hellas Ltd

Tel: +30 2100 100 002

Austria

Mylan Österreich GmbH

Tel: +43 1 86390

Spain

Viatris Pharmaceuticals, S.L.

Tel: +34 900 102 712

Poland

Viatris Healthcare Sp. z o.o.

Tel: + 48 22 546 64 00

France

Viatris Santé

Tel: + 33 (0)4 37 25 75 00

Portugal

Viatris Healthcare, Lda.

Tel: + 351 21 412 72 00

Croatia

Viatris Hrvatska d.o.o.

Tel: +385 1 23 50 599

Romania

BGP Products SRL

Tel: +40 372 579 000

Ireland

Mylan Ireland Limited

Tel: +353 1 8711600

Slovenia

Viatris d.o.o.

Tel: + 386 1 23 63 180

Iceland

Icepharma hf

Tel: +354 540 8000

Slovakia

Viatris Slovakia s.r.o.

Tel: +421 2 32 199 100

Italy

Viatris Italia S.r.l.

Tel: + 39 02 612 46921

Finland

Viatris Oy

Tel: +358 20 720 9555

Cyprus

Varnavas Hadjipanayis Ltd

Tel: +357 2220 7700

Sweden

Viatris AB

Tel: + 46 (0)8 630 19 00

Latvia

Viatris SIA

Tel: +371 676 055 80

United Kingdom (Northern Ireland)

Mylan IRE Healthcare Limited

+353 18711600

Belgium/Belgique/Belgien

Mylan EPD bvba/sprl

Tel: + 32 (0)2 658 61 00

Luxembourg/Luxemburg

Mylan EPD bvba/sprl

Tel: + 32 (0)2 658 61 00

(Belgium/Belgien)

Bulgaria

?????? ????

?: +359 2 44 55 400

Hungary

Mylan EPD Kft

Tel: + 36 1 465 2100

Czech Republic

Mylan Healthcare CZ s.r.o.

Tel: + 420 222 004 400

Malta

V.J. Salomone Pharma Ltd

Tel: + 356 21 22 01 74

Denmark

Viatris ApS

Tel: +45 28 11 69 32

Netherlands

Mylan Healthcare BV

Tel: +31 (0)20 426 3300

Germany

Mylan Healthcare GmbH

Tel: +49 800 0700 800

Norway

Mylan Healthcare Norge AS

Tel: + 47 66 75 33 00

Estonia

BGP Products Switzerland GmbH Eesti filiaal

Tel: + 372 6363 052

Austria

Mylan Österreich GmbH

Tel: +43 1 86390

Greece

BGP ΠΡΟ?ΟΝΤΑ Μ.Ε.Π.Ε.

Tel: +30 210 9891 777

Poland

Mylan Healthcare Sp. z o.o.

Tel: + 48 22 546 64 00

Spain

Mylan Pharmaceuticals, S.L.

Tel: +34 900 102 712

Portugal

BGP Products, Unipessoal, Lda.

Tel: + 351 21 412 72 56

France

Viatris Santé

Tel: + 33 (0)4 37 25 75 00

Romania

BGP Products SRL

Tel: +40 372 579 000

Croatia

Mylan Hrvatska d.o.o.

Tel: +385 1 23 50 599

Slovenia

Mylan Healthcare d.o.o.

Tel: + 386 1 23 63 180

Ireland

Mylan Ireland Limited

Tel: +353 1 8711600

Slovakia

Mylan s.r.o.

Tel: +421 2 32 199 100

Iceland

Icepharma hf

Tel: +354 540 8000

Finland

Viatris Oy

Tel: +358 20 720 9555

Italy

Mylan Italia S.r.l.

Tel: + 39 02 612 46921

Sweden

Mylan AB

Tel: + 46 855 522 750

Cyprus

Varnavas Hadjipanayis Ltd

Tel: +357 2220 7700

United Kingdom(Northern Ireland)

Mylan IRE Healthcare Limited

+353 18711600

Latvia

Mylan Healthcare SIA

Tel: +371 676 055 80

Lithuania

Mylan Healthcare UAB

Tel: +370 5 205 1288

Drawing 3. Syringe with a manualneedle protection system with the safety cap covering the needle AFTER USE

USE

Types of Safety Syringes:

There are two types of safety syringes for Arixtra, designed to protect against accidental needlesticks after use. One type of syringe has an automaticneedle protection system and the other has a manualsystem.

Syringe Components:

  • Needle protector

? Plunger

? Grip area (with fingers)

  • Needle safety cap

Drawing 1. Syringe with an automaticneedle protection system

Pre-filled syringe with numbered plunger from 1 to 5 and visible metal needle

Syringe with a manualneedle protection system

Drawing 2. Syringe with a manualneedle protection system

Syringe with medication and needle, hand holding the syringe and inserting the needle with an arrow indicating the direction

DESCRIPTION OF ARIXTRA USE MODEInstructions for Use

These instructions apply to both types of syringes (with automatic and manual needle protection systems).

When there is a different instruction between syringes, it will be clearly specified.

  1. Wash your handscarefully with water and soap and dry them with a towel.

  1. Remove the syringe from the packaging and check that:

  • the expiration date has not passed
  • the solution is transparent and colorless and does not contain particles
  • the syringe has not been opened or damaged
  1. Sit or lie down in a comfortable position.Select a point in the lower abdomen (belly), at least 5 cm below the navel (drawing A).

For each injection, alternate the left and right sidesof the lower abdomen. This will help reduce discomfort at the injection site.

If injection in the lower abdomen is not possible, ask your doctor.

Two schematic human figures showing gray areas on the torso and upper arm indicating injection sites

Drawing A

  1. Clean the injection area with a swab or cotton ball impregnated with alcohol.

  1. Remove the needle protector: first by twisting (drawing B1) and then by pulling it out from the syringe body (drawing B2).

Discard the needle protector.

Important Note

  • Do not touch the needleand prevent it from coming into contact with any surface before injection.
  • It is normal to find a small air bubble in the syringe. Do not try to remove this air bubblebefore administering the injectionas you may lose part of the medication.
  1. Gently pinch the skin you previously cleanedto form a fold. Hold the fold between your thumb and index finger throughout the injection (drawing C).
  1. Hold the syringe firmly by the grip area. Insert the needle into the skin fold at a right angle (drawing D).

Drawing B1

Hand holding syringe with needle inserted in foot, showing subcutaneous injection technique on the back of the foot

Drawing B2

Hands holding and pinching the skin of the arm preparing for a subcutaneous injection

Drawing C

Hand holding syringe with needle inserted in the skin, arrow indicating direction of injection and cotton ball near the point

Drawing D

  1. Inject the entire contents of the syringeby pressing the plunger down to the maximum (drawing E).

Hand holding an auto-injector with the needle pointing downwards and being inserted into the skin of the thigh

Drawing E

Syringe with automatic system

Hand holding syringe with needle inserted in the skin showing the angle and formation of a skin fold

  1. Release the plungerand the needle will automatically move from the skin to a safety cap where it will be permanently locked (drawing F).

Drawing F

Syringe with manual system

  1. After injection, hold the syringe by the needle safety cap with the fingers of one hand, grasp the grip area with the fingers of the other hand, and pull back. This action releases the cap. Slide the cap along the syringe body until it is locked in a position that covers the needle, as shown in drawing 3.

Do not dispose of the used needle in the trash can. Dispose of it according to the instructions given by your doctor or pharmacist.

Online doctors for ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe

Discuss questions about ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe?
ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe?
The active ingredient in ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe is fondaparinux. This information helps identify medicines with the same composition but different brand names.
How much does ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe cost in pharmacies?
The average pharmacy price for ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe is around 87.9 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe?
ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe is manufactured by Viatris Healthcare Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ARIXTRA 2.5 mg/0.5 mL Injectable Solution, Prefilled Syringe?
Other medicines with the same active substance (fondaparinux) include ARIXTRA 1.5 mg/0.3 mL Injectable Solution, Prefilled Syringe, ARIXTRA 5 mg/0.4 mL Injectable Solution, Prefilled Syringe, ARIXTRA 7.5 mg/0.6 mL Injectable Solution, Prefilled Syringe. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media